Sarcoidosis is a multisystem disease, manifesting with cutaneous involvement in approximately 25% of patients.1 Lesions present in a wide variety of forms, including lupus pernio, violaceous papules and plaques, subcutaneous nodules, alopecia, ichthyosis, or verrucous growths. We describe a woman with cutaneous sarcoidosis refractory to treatment with multiple systemic agents who improved dramatically with infliximab therapy.
Heffernan MP, Anadkat MJ. Recalcitrant Cutaneous Sarcoidosis Responding to Infliximab. Arch Dermatol. 2005;141(7):910–911. doi:10.1001/archderm.141.7.910
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: